Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy. - Beygui F; Roule V; Gandjbakhch E; Ollitrault P; Silvain J; Milliez P; Vignolles N; Zeitouni M; Guedeney P; Champ-Rigot L; Blanchart K; Montalescot G (Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2025)